Zobrazeno 1 - 10 of 30 pro vyhledávání: '"Lluis Ramió‐Torrentà"'
3
Akademický článek
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
Autor: Pablo Aliaga-Gaspar, Isaac Hurtado-Guerrero, Nicolas Lundahl Ciano-Petersen, Patricia Urbaneja, Isabel Brichette-Mieg, Virginia Reyes, Jose Luis Rodriguez-Bada, Roberto Alvarez-Lafuente, Rafael Arroyo, Ester Quintana, Lluis Ramió-Torrentà, Ana Alonso, Laura Leyva, Oscar Fernández, Begoña Oliver-Martos
Publikováno v: Frontiers in Immunology, Vol 12 (2021)
PurposeInterferon beta receptor 2 subunit (IFNAR2) can be produced as a transmembrane protein, but also as a soluble form (sIFNAR2) generated by alternative splicing or proteolytic cleavage, which has both agonist and antagonist activities for IFN-β
Externí odkaz: https://doaj.org/article/5912837c529b4315bf6dcc4468e175fb
Zobrazit plný text záznamu
4
Akademický článek
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
Autor: Paulette Esperanza Walo-Delgado, Enric Monreal, Silvia Medina, Ester Quintana, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Paloma Lapuente, Manuel Comabella, Lluis Ramió-Torrentà, Xavier Montalban, Luciana Midaglia, Noelia Villarrubia, Angela Carrasco-Sayalero, Eulalia Rodríguez-Martín, Ernesto Roldán, José Meca-Lallana, Roberto Alvarez-Lafuente, Jaime Masjuan, Lucienne Costa-Frossard, Luisa Maria Villar
Publikováno v: Frontiers in Immunology, Vol 12 (2021)
ObjectiveTo explore if baseline blood lymphocyte profile could identify relapsing remitting multiple sclerosis (RRMS) patients at higher risk of developing secondary autoimmune adverse events (AIAEs) after alemtuzumab treatment.MethodsMulticenter pro
Externí odkaz: https://doaj.org/article/db6b5f4929b24c10a2068757d7ba4fb7
Zobrazit plný text záznamu
5
Akademický článek
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
Autor: Francisco Carlos Pérez‐Miralles, Daniel Prefasi, Antonio García‐Merino, José Ramón Ara, Guillermo Izquierdo, Virginia Meca‐Lallana, Francisco Gascón‐Giménez, María Luisa Martínez‐Ginés, Lluis Ramió‐Torrentà, Lucienne Costa‐Frossard, Óscar Fernández, Sara Moreno‐García, Jorge Maurino, Joan Carreres‐Polo, Bonaventura Casanova
Publikováno v: Brain and Behavior, Vol 11, Iss 4, Pp n/a-n/a (2021)
Abstract Background and purpose Evidence on regional changes resulting from neurodegenerative processes underlying primary progressive multiple sclerosis (PPMS) is still limited. We assessed brain region volumes and their relationship with disability
Externí odkaz: https://doaj.org/article/1c68c742d928479ab6b1cd9c261aafe7
Zobrazit plný text záznamu
6
Akademický článek
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Autor: Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, Rafael Arroyo, Harald Hegen, Florian Deisenhammer, Susana Sainz de la Maza, José C. Alvarez-Cermeño, Guillermo Izquierdo, Dolores Paramo, Pedro Oliva, Bonaventura Casanova, Eduardo Agüera-Morales, Diego Franciotta, Matteo Gastaldi, Oscar Fernández, Patricia Urbaneja, José M. Garcia-Dominguez, Fernando Romero, Alicia Laroni, Antonio Uccelli, Angel Perez-Sempere, Albert Saiz, Yolanda Blanco, Daniela Galimberti, Elio Scarpini, Carmen Espejo, Xavier Montalban, Ludwig Rasche, Friedemann Paul, Inés González, Elena Álvarez, Cristina Ramo, Ana B. Caminero, Yolanda Aladro, Carmen Calles, Pablo Eguía, Antonio Belenguer-Benavides, Lluis Ramió-Torrentà, Ester Quintana, José E. Martínez-Rodríguez, Agustín Oterino, Carlos López de Silanes, Luis I. Casanova, Lamberto Landete, Jette Frederiksen, Gabriel Bsteh, Patricia Mulero, Manuel Comabella, Miguel A. Hernández, Mercedes Espiño, José M. Prieto, Domingo Pérez, María Otano, Francisco Padilla, Juan A. García-Merino, Laura Navarro, Alfonso Muriel, Lucienne Costa Frossard, Luisa M. Villar
Publikováno v: Frontiers in Neurology, Vol 11 (2020)
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. W
Externí odkaz: https://doaj.org/article/c82f6fa684d240fe86a6b469a1788aa1
Zobrazit plný text záznamu
8
Akademický článek
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression
Autor: Maria Inmaculada Dominguez-Mozo, Victoria Galán, Lluís Ramió-Torrentà, Ana Quiroga, E. Quintana, Luisa María Villar, Lucienne Costa-Frossard, José Ignacio Fernández-Velasco, Noelia Villarrubia, María Angel Garcia-Martinez, Rafael Arroyo, Roberto Alvarez-Lafuente
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
BackgroundAlthough fingolimod, a sphingosine 1-phosphate receptor agonist, has shown to be an effective treatment reducing relapse rate and also slowing down the disability progression in relapsing-remitting multiple sclerosis (RRMS) patients, it is
Externí odkaz: https://doaj.org/article/c63de789e911437c9e48eaea8653154e
Zobrazit plný text záznamu
9
Akademický článek
Lower serum ferritin levels are associated with worse cognitive performance in aging
Autor: Marisel Rosell-Díaz, Elena Santos-González, Anna Motger-Albertí, Laura Gallardo-Nuell, María Arnoriaga-Rodríguez, Clàudia Coll-Martínez, Lluís Ramió-Torrentà, Josep Garre-Olmo, Josep Puig, Rafael Ramos, Jordi Mayneris-Perxachs, José Manuel Fernández-Real
Publikováno v: The Journal of Nutrition, Health and Aging, Vol 28, Iss 4, Pp 100190- (2024)
Objectives: Iron is important for neurogenesis, synaptic development, and neurotransmitter synthesis. Serum ferritin (SF) is a reliable marker for assessing iron stores. Therefore, we evaluated the cognitive function associated with SF levels. We als
Externí odkaz: https://doaj.org/article/1e0edfd2417e4281ba344b858cc69185
Zobrazit plný text záznamu
10
Akademický článek
Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis
Autor: Óscar Fernández Fernández, Lucienne Costa-Frossard, Maria Luisa Martínez Ginés, Paloma Montero Escribano, José María Prieto González, Lluís Ramió-Torrentà, Yolanda Aladro, Ana Alonso Torres, Elena Álvarez Rodríguez, Andrés Labiano-Fontcuberta, Lamberto Landete Pascual, Ambrosio Miralles Martínez, Ester Moral Torres, Pedro Oliva-Nacarino
Publikováno v: Frontiers in Neurology, Vol 15 (2024)
IntroductionThe Spasticity-Plus Syndrome (SPS) in multiple sclerosis (MS) refers to a combination of spasticity and other signs/symptoms such as spasms, cramps, bladder dysfunction, tremor, sleep disorder, pain, and fatigue. The main purpose is to de
Externí odkaz: https://doaj.org/article/60412756c06b4332b1107302498e9bb2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje